BioTelemetry, a Philips company
In this free webinar, Richard Ehman, MD from the Mayo Clinic and BioTel Research’s Jonathan Riek, PhD, VP, Musculoskeletal and Metabolic Imaging discuss non-invasive ways to assess NASH using imaging, including proton density fat fraction (PDFF), T1 relaxometry, magnetic resonance elastography (MRE), and the latest advances in MRE.
In this free webinar, Ed Ashton, PhD, Vice President of Oncology Imaging and Danielle Lewis, MS, PMP, Global Operations Account Manager, present real-world scientific and operational examples of errors that can occur during your imaging clinical trial and how you can prevent them.
In this free webinar, Polina Voloshko, MD, Chief Medical Officer and Daniel Goodman, MD, Vice President and Medical Director, present the updates from the 2017 CSRC/FDA meeting on cardiac safety and cardiovascular safety issues in oncology drug development to optimize your clinical trial.
In this free webinar, BioTel Research’s Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, present alternative, noninvasive imaging methods to determine body composition. Watch Webinar
Join Svetlana Kolchinsky, Director of Project Operations, as she discusses how to manage multi-protocol programs and build efficiencies while being a good partner. Key topics include next level planning for risk management and project/program oversight, successful project delivery and lessons learned.
In this free webinar, industry experts Edward Ashton, PhD and Polina Voloshko, MD will discuss the growing range of imaging modalities and analysis methods that are available for use in your clinical trials during oncology drug development.
BioTel Research is proposing a service offering for evaluation of cardiac repolarization in early human trials, novel to the industry, called Dynamic Repolarization Analysis.
In this free webinar, industry experts Sandra Chica, MD and Polina Voloshko, MD aim to describe novel medical imaging approaches and methodologies to help sponsors maximize clinical trial efficiency along the development pathway.
In this free webinar learn how big data is transforming cardiac research. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTel Research, and Wayne M. Derkac, MD, Vice President of Medical Affairs, BioTelemetry.
Please join us for this free webinar on trends in event and continuous ECG monitoring, and implications for clinical trials of both medical devices and drug therapies. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTel Research. Download Full Slide Presentation
Learn from industry expert, Dr. Tim Callahan at this free webinar on the development of clinical trials using targeted agents has been stimulated by the identification of pathways involved in carcinogenesis, metastasis and drug resistance and by the emergence of molecular analysis of tumors.
Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple steatosis and nonalcoholic steatohepatitis (NASH). Patients with non-alcoholic fatty liver disease (NAFLD) are at risk of steatohepatitis and progressive liver fibrosis culminating in cirrhosis, typically over
This webinar is co-sponsored by the Cardiac Safety Research Consortium, and will be moderated by Jonathan Seltzer, MD, FACC – CSRC Executive Director.
Join Philips BioTel Heart for a virtual round table discussion of the past, present and future challenges and solutions providers encounter in the remote management of cardiac patients.
In this webinar, Ryan Augenstein and the BioTel Heart EMR team discuss how their successful EMR integration at Parkview Health helped improve the workflow, efficiency, and overall patient care.
In this webinar, Dr. Sanjaya Gupta, MD, FACC, FHRS shares insight on why choosing to prescribe MCOT® and ePatch™ allows him to better monitor, treat and care for his patients.
In this webinar, Dr. Kabir Bhasin, MD, FACC, Cardiac Electrophysiologist, discusses his post-TAVR monitoring experiences with MCOT at Northwell Lenox Hill Hospital.
In this webinar, Dr. Kabir Bhasin, MD, FACC, Cardiac Electrophysiologist, discusses his post-TAVR monitoring experiences with MCOT at Northwell Lenox Hill Hospital.
In this webinar, Dr. Sanjaya Gupta, MD, FACC, FHRS shares insight on why choosing to prescribe MCOT® and ePatch™ allows him to better monitor, treat and care for his patients.
In this webinar, Ryan Augenstein and the BioTel Heart EMR team discuss how their successful EMR integration at Parkview Health helped improve the workflow, efficiency, and overall patient care.
Join Philips BioTel Heart for a virtual round table discussion of the past, present and future challenges and solutions providers encounter in the remote management of cardiac patients.
This webinar is co-sponsored by the Cardiac Safety Research Consortium, and will be moderated by Jonathan Seltzer, MD, FACC – CSRC Executive Director.
Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple steatosis and nonalcoholic steatohepatitis (NASH). Patients with non-alcoholic fatty liver disease (NAFLD) are at risk of steatohepatitis and progressive liver fibrosis culminating in cirrhosis, typically over a
Learn from industry expert, Dr. Tim Callahan at this free webinar on the development of clinical trials using targeted agents has been stimulated by the identification of pathways involved in carcinogenesis, metastasis and drug resistance and by the emergence of molecular analysis of tumors.
Please join us for this free webinar on trends in event and continuous ECG monitoring, and implications for clinical trials of both medical devices and drug therapies. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTel Research. Download Full Slide Presentation
In this free webinar learn how big data is transforming cardiac research. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTel Research, and Wayne M. Derkac, MD, Vice President of Medical Affairs, BioTelemetry.
In this free webinar, industry experts Sandra Chica, MD and Polina Voloshko, MD aim to describe novel medical imaging approaches and methodologies to help sponsors maximize clinical trial efficiency along the development pathway.
BioTel Research is proposing a service offering for evaluation of cardiac repolarization in early human trials, novel to the industry, called Dynamic Repolarization Analysis.
In this free webinar, industry experts Edward Ashton, PhD and Polina Voloshko, MD will discuss the growing range of imaging modalities and analysis methods that are available for use in your clinical trials during oncology drug development.
Join Svetlana Kolchinsky, Director of Project Operations, as she discusses how to manage multi-protocol programs and build efficiencies while being a good partner. Key topics include next level planning for risk management and project/program oversight, successful project delivery and lessons learned.
In this free webinar, BioTel Research’s Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, present alternative, noninvasive imaging methods to determine body composition. Watch Webinar
In this free webinar, Polina Voloshko, MD, Chief Medical Officer and Daniel Goodman, MD, Vice President and Medical Director, present the updates from the 2017 CSRC/FDA meeting on cardiac safety and cardiovascular safety issues in oncology drug development to optimize your clinical trial.
In this free webinar, Ed Ashton, PhD, Vice President of Oncology Imaging and Danielle Lewis, MS, PMP, Global Operations Account Manager, present real-world scientific and operational examples of errors that can occur during your imaging clinical trial and how you can prevent them.
In this free webinar, Richard Ehman, MD from the Mayo Clinic and BioTel Research’s Jonathan Riek, PhD, VP, Musculoskeletal and Metabolic Imaging discuss non-invasive ways to assess NASH using imaging, including proton density fat fraction (PDFF), T1 relaxometry, magnetic resonance elastography (MRE), and the latest advances in MRE.
© 2023 BioTelemetry, a Philips Company. All rights reserved